SCHEMBL6330490

SCHEMBL6330490

COc1ccc2c(ccn2S(=O)(=O)c2ccc3c(c2)CNCC3)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 11/20 0.61
CYP3A4 P08684 2/20 0.61
POLB P06746 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
HDAC1 Q13547 4/20 0.53
HDAC6 Q9UBN7 3/20 0.53
PNMT P11086 4/20 0.49
HDAC3 O15379 2/20 0.48
HDAC8 Q9BY41 2/20 0.48
HDAC4 P56524 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HDAC5 Q9UQL6 1/20 0.48
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ADRA2A P08913 1/20 0.46
ADRA2B P18089 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6338119 0.92 HTR6 (0.61) HTR6CYP3A4POLBL3MBTL1PNMT
SCHEMBL6336148 0.84 HTR6 (0.63) HTR6CYP3A4PNMTADRA2AADRA2B
SCHEMBL6338171 0.84 HTR6 (0.54) HTR6CYP3A4PNMTADRA2AADRA2B
SCHEMBL6330318 0.84 HTR6 (0.54) HTR6CYP3A4L3MBTL1PNMTMEN1
SCHEMBL6329311 0.83 PNMT (0.49) HTR6CYP3A4L3MBTL1PNMTMEN1
SCHEMBL6328762 0.82 HTR6 (0.62) HTR6CYP3A4L3MBTL1PNMTMEN1
Hydrochloric Acid SCHEMBL6329781 0.81 HTR6 (0.61) HTR6CYP3A4L3MBTL1PNMTMEN1
SCHEMBL6332952 0.80 HTR6 (0.55) HTR6CYP3A4PNMTADRA2AADRA2B
SCHEMBL6332254 0.79 PNMT (0.52) HTR6CYP3A4PNMTADRA2AADRA2B
SCHEMBL949712 0.79 HTR6 (0.84) HTR6CYP3A4POLBL3MBTL1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6849644-B2 Isoquinoline derivatives useful in the treatment of CNS disorders SMITHKLINE BEECHAM P.L.C. (GB) 2005-02-01 US claimed
US-6849644-B2 Isoquinoline derivatives useful in the treatment of CNS disorders SMITHKLINE BEECHAM P.L.C. (GB) 2005-02-01 US disclosed